1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Physician toxicity attribution in phase I trials: Evaluating the effect of dose on the frequency of 11,909 toxicities
    Meeting Abstract

    Eaton, A.; Iasonos, A.; Gounder, M. M.; Pamer, E.; Drilon, A. E.; Vulih, D.; Smith, G. L.; Ivy, P.; Spriggs, D. R.; Hyman, D. M.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phenotypic correlation of tumor uptake of exogenous glutamine radiotracer versus tumor mutational status
    Meeting Abstract

    Dunphy, M.; Harding, J. J.; Lewis, J. S.; Mellinghoff, I. K.; Omuro, A. M. P.; Hsieh, J.; Zhang, H. W.; Zanzonico, P.; Venneti, S.; Carlin, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Assessment of second-line VEGF-inhibitor therapy in radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC)
    Meeting Abstract

    Dunn, L.; Ho, A. L.; Haque, S.; Fury, M. G.; Baxi, S. S.; Cullen, G.; Pfister, D. G.; Sherman, E. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A. E.; Sima, C. S.; Somwar, R.; Smith, R.; Ginsberg, M. S.; Riely, G. J.; Rudin, C. M.; Ladanyi, M.; Kris, M. G.; Rizvi, N. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Dermatologic toxicities of 3,517 solid tumor patients on phase I clinical trials of the National Institutes of Health Cancer Therapy Evaluation Program (CTEP)
    Meeting Abstract

    Drilon, A. E.; Eaton, A.; Schindler, K.; Gounder, M. M.; Smith, G. L.; Vulih, D.; Harris, P. J.; Spriggs, D. R.; Ivy, P.; Iasonos, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase III trial evaluating the addition of bevacizumab to letrozole as first-line endocrine therapy for treatment of hormone-receptor positive advanced breast cancer: CALGB 40503 (Alliance)
    Meeting Abstract

    Dickler, M. N.; Barry, W. T.; Cirrincione, C. T.; Ellis, M. J.; Moynahan, M. E.; Innocenti, F.; Hurria, A.; Rugo, H. S.; Lake, D.; Hahn, O. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Crossover in oncology clinical trials
    Meeting Abstract

    Diaz, J.; Sternberg, C. N.; Mehmud, F.; Delea, T. E.; Latimer, N.; Bartlett-Pandite, A. N.; Motzer, R.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A randomized phase III study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with advanced liposarcoma (LPS) or leiomyosarcoma (LMS)
    Meeting Abstract

    Demetri, G. D.; von Mehren, M.; Jones, R. L.; Hensley, M. L.; Schuetze, S.; Staddon, A. P.; Milhem, M. M.; Elias, A. D.; Ganjoo, K. N.; Tawbi, H. A. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prognostic value of genomic signatures in metastatic clear cell renal cell carcinoma (mRCC) using The Cancer Genome Atlas (TCGA) data
    Meeting Abstract

    de Velasco, G.; Fay, A. P.; Culhane, A.; Hakimi, A. A.; Voss, M. H.; Tannir, N. M.; Tamboli, P.; Appleman, L. J.; Bellmunt, J.; Rathmell, K.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Long-term efficacy of pembrolizumab (pembro; MK-3475) in a pooled analysis of 655 patients (pts) with advanced melanoma (MEL) enrolled in KEYNOTE-001
    Meeting Abstract

    Daud, A.; Ribas, A.; Robert, C.; Hodi, F. S.; Wolchok, J. D.; Joshua, A. M.; Hwu, W. J.; Weber, J. S.; Gangadhar, T. C.; Joseph, R. W.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save